<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03613077</url>
  </required_header>
  <id_info>
    <org_study_id>CR2017-03</org_study_id>
    <nct_id>NCT03613077</nct_id>
  </id_info>
  <brief_title>A Non-Interventional Study to Document the Use of Straumann BLX Implants in Daily Dental Practice</brief_title>
  <acronym>BLX_NIS</acronym>
  <official_title>A Non-Interventional Study to Document the Use of Straumann BLX Implants in Daily Dental Practice</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Straumann AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut Straumann AG</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, multi-center, non-interventional observation to document the success and
      survival rates of Straumann BLX Implants used for tooth replacement in cleared indications up
      to 1 year after implant placement
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective of the study is to confirm the safety and performance of Straumann BLX Implants
      used for tooth replacement in cleared indications up to 12 months after implant placement.
      Implants used are Straumann® BLX Implant Roxolid® SLActive®. Regular Base (3.5 mm): implant
      diameters 3.75 and 4.5mm, in lengths 6, 8, 10, 12,14, 16 and 18 mm Wide Base (4.5 mm):
      diameter 5.5 mm in lengths 6, 8, 10 and 12 mm
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 14, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 28, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Implant success rate at one year post implant placement</measure>
    <time_frame>12 months follow-up period after implantation</time_frame>
    <description>Measured in percent</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Implant survival rate at one year post implant placement</measure>
    <time_frame>12 months follow-up period after implantation</time_frame>
    <description>Measured in percent</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prosthetic success at 12 months post implant placement</measure>
    <time_frame>12 months follow-up period after implantation</time_frame>
    <description>Measured in percent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prosthetic survival at 12 months post implant placement</measure>
    <time_frame>12 months follow-up period after implantation</time_frame>
    <description>Measured in percent</description>
  </secondary_outcome>
  <enrollment type="Actual">151</enrollment>
  <condition>Surgical Operation With Implant of Artificial Internal Device</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>surgical placement of an endosteal implant</intervention_name>
    <description>Subjects, male or female at least 18 years old, with the need of dental implant therapy and restoration according to the cleared indications for the implant</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients seeking an implant supported restoration
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients seeking an implant supported restoration

          -  all patients with conditions that are in accordance with the IFU

          -  Patients must provide their informed consent for study participation and must be
             willing and able to attend control visits

          -  Patients need to be at least 18 years old

        Exclusion Criteria:

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian Walter, Prof. Dr.Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mediplus Praxisklinik</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mediplus Praxisklinik</name>
      <address>
        <city>Mainz</city>
        <zip>55128 Mainz</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>July 11, 2018</study_first_submitted>
  <study_first_submitted_qc>July 27, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 2, 2018</study_first_posted>
  <last_update_submitted>May 11, 2020</last_update_submitted>
  <last_update_submitted_qc>May 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Survival rate</keyword>
  <keyword>Success rate</keyword>
  <keyword>Straumann® BLX Implant Roxolid® SLActive®,</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

